MRI Shows Brain Anatomy Differences Between Autistic and Typically Developing Individuals to Be Mostly Indistinguishable
By MedImaging International staff writers Posted on 24 Nov 2014 |

Image: Differences in the brains of autistic and control subjects using MRI (Photo courtesy of Center of Cognitive Brain Imaging, Carnegie Mellon University).

Image: MR diffusion spectrum imaging (DSI) used to examine the structural integrity of white matter in people with autism and typical participants. These imaging techniques visualize axonal tracts by measuring the diffusion of water along white matter fibers (Photo courtesy of Center of Cognitive Brain Imaging, Carnegie Mellon University).
In the largest magnetic resonance imaging (MRI) study of patients with autism to date, Israeli and American researchers have shown that the brain anatomy in MRI scans of autistic individuals older than age six is mostly indistinguishable from that of typically developing individuals, and therefore, of little clinical or scientific value.
The researchers from Ben-Gurion University of the Negev (BGU; Be’er Sheva, Israel) and Carnegie Mellon University (Pittsburgh, PA, USA) published their findings online October 14, 2014, in the Oxford journal Cerebral Cortex. “Our findings offer definitive answers regarding several scientific controversies about brain anatomy, which have occupied autism research for the past 10 to 15 years,” said Dr. Ilan Dinstein of BGU’s departments of psychology and brain and cognitive sciences. “Previous hypotheses suggesting that autism is associated with larger intracranial gray matter, white matter, and amygdala volumes, or smaller cerebellar, corpus callosum and hippocampus volumes were mostly refuted by this new study.”
The researchers used data from the Autism Brain Imaging Data Exchange (ABIDE), which provides an unprecedented prospect to conduct large-scale comparisons of anatomic MRI scans across autism and control groups and resolve many outstanding questions. This recently released database is a worldwide collection of MRI scans from over 1,000 individuals (half with autism and half controls) ages 6 to 35 years old.
“In the study we performed very detailed anatomical examinations of the scans, which included dividing each brain into over 180 regions of interest and assessing multiple anatomical measures such as the volume, surface area and thickness of each region,” Dr. Dinstein stated.
The researchers then examined how the autism and control groups differed with respect to each region and also with respect to groups of regions using more complex analyses. “The most striking finding here was that anatomical differences within both the control group and the autistic group was immense and greatly overshadowed minute differences between the two groups,” Dr. Dinstein noted. “For example, individuals in the control group differ by 80% to 90% in their brain volumes, while differences in brain volume across autism and control groups differed by 2% to 3% percent at most. This led us to the conclusion that anatomical measures of brain volume or surface areas do not offer much information regarding the underlying mechanism or pathology of autistic spectrum disorder [ASD],” he stated. “These sobering results suggest that autism is not a disorder that is associated with specific anatomical pathology and as a result, anatomical measures alone are likely to be of low scientific and clinical significance for identifying children, adolescents and adults with ASD, or for elucidating their neuropathology.”
Dr. Dinstein believes that more complicated explanations involving combinations of measures in more homogeneous subgroups are in all probability to be the answer. “Expecting to find a single answer for the entire ASD population is naive. We need to move on to thinking about how to split up this very heterogeneous group of disorders into more meaningful biologically-relevant subgroups,” he stated.
This conclusion stands in great contrast to numerous reports of significant anatomical differences described by smaller studies, which have typically included comparisons of 40 to 50 individuals. “The problem with small samples, large within-group heterogeneity, and a scientific bias to report only positive findings, is that small samples are likely to yield significant differences across autism and control groups in a few of the 180 brain regions,” Dr. Dinstein explained.
“In such a situation one would expect that each study would find significant differences in different brain areas and that findings will be very inconsistent across studies," he says. "This is exactly what you see when you examine the autism anatomy literature from the last decade or so. Our study simply explains why this has been happening and puts an end to several ensuing debates.”
Related Links:
Ben-Gurion University of the Negev
Center of Cognitive Brain Imaging, Carnegie Mellon University
Carnegie Mellon University
The researchers from Ben-Gurion University of the Negev (BGU; Be’er Sheva, Israel) and Carnegie Mellon University (Pittsburgh, PA, USA) published their findings online October 14, 2014, in the Oxford journal Cerebral Cortex. “Our findings offer definitive answers regarding several scientific controversies about brain anatomy, which have occupied autism research for the past 10 to 15 years,” said Dr. Ilan Dinstein of BGU’s departments of psychology and brain and cognitive sciences. “Previous hypotheses suggesting that autism is associated with larger intracranial gray matter, white matter, and amygdala volumes, or smaller cerebellar, corpus callosum and hippocampus volumes were mostly refuted by this new study.”
The researchers used data from the Autism Brain Imaging Data Exchange (ABIDE), which provides an unprecedented prospect to conduct large-scale comparisons of anatomic MRI scans across autism and control groups and resolve many outstanding questions. This recently released database is a worldwide collection of MRI scans from over 1,000 individuals (half with autism and half controls) ages 6 to 35 years old.
“In the study we performed very detailed anatomical examinations of the scans, which included dividing each brain into over 180 regions of interest and assessing multiple anatomical measures such as the volume, surface area and thickness of each region,” Dr. Dinstein stated.
The researchers then examined how the autism and control groups differed with respect to each region and also with respect to groups of regions using more complex analyses. “The most striking finding here was that anatomical differences within both the control group and the autistic group was immense and greatly overshadowed minute differences between the two groups,” Dr. Dinstein noted. “For example, individuals in the control group differ by 80% to 90% in their brain volumes, while differences in brain volume across autism and control groups differed by 2% to 3% percent at most. This led us to the conclusion that anatomical measures of brain volume or surface areas do not offer much information regarding the underlying mechanism or pathology of autistic spectrum disorder [ASD],” he stated. “These sobering results suggest that autism is not a disorder that is associated with specific anatomical pathology and as a result, anatomical measures alone are likely to be of low scientific and clinical significance for identifying children, adolescents and adults with ASD, or for elucidating their neuropathology.”
Dr. Dinstein believes that more complicated explanations involving combinations of measures in more homogeneous subgroups are in all probability to be the answer. “Expecting to find a single answer for the entire ASD population is naive. We need to move on to thinking about how to split up this very heterogeneous group of disorders into more meaningful biologically-relevant subgroups,” he stated.
This conclusion stands in great contrast to numerous reports of significant anatomical differences described by smaller studies, which have typically included comparisons of 40 to 50 individuals. “The problem with small samples, large within-group heterogeneity, and a scientific bias to report only positive findings, is that small samples are likely to yield significant differences across autism and control groups in a few of the 180 brain regions,” Dr. Dinstein explained.
“In such a situation one would expect that each study would find significant differences in different brain areas and that findings will be very inconsistent across studies," he says. "This is exactly what you see when you examine the autism anatomy literature from the last decade or so. Our study simply explains why this has been happening and puts an end to several ensuing debates.”
Related Links:
Ben-Gurion University of the Negev
Center of Cognitive Brain Imaging, Carnegie Mellon University
Carnegie Mellon University
Latest MRI News
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
- New Model Makes MRI More Accurate and Reliable
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more